Drug intelligence / Profile preview

Cetaphil Restoraderm

Development stage
Unknown
Lead developer
Galderma
Administration
Topical
01

Overview

Cetaphil Restoraderm is a specialized line of over-the-counter therapeutic skincare products developed by Galderma for the management of eczema-prone and atopic skin. The formulation utilizes a combination of ceramide technology and filaggrin breakdown products, such as arginine and sodium pyrrolidone carboxylic acid (PCA), to replenish the skin's natural moisturizing factor (NMF) and restore the epidermal barrier. By strengthening the skin barrier, the product helps to reduce transepidermal water loss and protect against external irritants and allergens that trigger flares. Clinical evidence supports its use in reducing the incidence of atopic dermatitis in high-risk infants and improving symptoms such as pruritus and skin dryness in adults and children with mild-to-moderate eczema.

Brand names
Cetaphil RestoradermCetaphil PRO Restoraderm
Other names
Cetaphil Restoraderm Soothing MoisturizerCetaphil Restoraderm Eczema Soothing MoisturizerCetaphil Restoraderm Eczema Soothing Moisturizer with Filaggrin and Ceramide Technology

Beyond the preview

Go deeper on Cetaphil Restoraderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetaphil Restoraderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call